Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

P B

113 indexed publications match this author name.

ORCID: 0000-0002-5013-5144
OpenAlex: https://openalex.org/A5027965558

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 44 Mechanism of Action 34 Clinical Trial 30 Review Article 26 Safety 26 Observational Study 21 Receptor Pharmacology 21 Anxiety 20 Addiction 19 Brain Imaging 14 Treatment-Resistant Depression 13 Emotional Processing 11

Journals

Drug and Alcohol Dependence 5 Journal of psychopharmacology (Oxford, England) 4 Research Square 4 Molecular psychiatry 3 Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology 3 Journal of affective disorders 3 Journal of psychoactive drugs 3 Chembiochem: a European journal of chemical biology 3

Publication history

Psychedelic-induced hypomania and mania: a systematic review and meta-analysis.Molecular psychiatry · 2026-10-01 Reduced egocentricity after psilocybin in patients with alcohol use disorder: a pilot randomized controlled trialmedRxiv · 2026-09-29 A suite of engineered mice for interrogating psychedelic drug actions.Nature neuroscience · 2026-09-01 Differential effects of psilocybin derivatives on fentanyl-induced conditioned place preference in male and female mice.Journal of psychopharmacology (Oxford, England) · 2026-08-30 Beyond psilocybin: Do magic mushroom preparations contain other compounds with pharmacological effects?Authorea Preprints · 2026-07-30 Psilocybin-Assisted Early Palliative Care for Demoralization and Chronic Pain: An Open-Label Pilot Study.medRxiv: the preprint server for health sciences · 2026-07-14 Psychedelics produce enduring enhancement of reward responsiveness in male rats.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2026-07-10 Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in ratsCell Reports Medicine · 2026-07-01 Anthracaurisin A─Discovery of a Cytotoxic -Sesquiterpene Dimer from Patagonian.Journal of natural products · 2026-06-26 Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review.Schizophrenia research · 2026-06-01 Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headacheJournal of Psychopharmacology · 2026-05-29 A128-Channel Wireless Wearable Myolink (W2 Myolink): Functional Characteristics and Multidisciplinary ExperimentsResearch Square · 2026-04-28 Psilocybin’s Kinematic Effect on Manual DexterityResearch Square · 2026-04-15 Complete biosynthesis of psychedelic tryptamines from three kingdoms in plants.Science advances · 2026-04-03 New treatments for OCD? Evidence for cannabinoids and psychedelics.Journal of psychiatric research · 2026-02-01 Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia's clinical landscape.The Australian and New Zealand journal of psychiatry · 2026-02-01 Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].Journal of affective disorders · 2026-01-15 The Effect of Magic Mushroom (Psilocybe azurescens) on Social Interaction, Anxiety- and Depressive-Like Behaviors in Male Rats; the Role of Neuroinflammation, Oxidative Stress, and Neurotrophic Factors.Journal of neuroscience research · 2026-01-01 The CAnadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT): A Multi-Phase Program Overview.Current oncology (Toronto, Ont.) · 2025-12-22 Which Psychotherapy Model Should be Used in Psilocybin Treatment for Depression?Trends in psychiatry and psychotherapy · 2025-12-17 Real-World Psilocybin Therapy for Treatment-Resistant Depression: a Retrospective Observational StudyResearch Square · 2025-12-10 Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping ReviewQeios · 2025-12-09 Above the threshold, beyond the trip: the role of the 5-HT receptor in psychedelic-induced neuroplasticity and antidepressant effects.Molecular psychiatry · 2025-12-01 Psilocybin as a fast-acting and long-lasting antidepressant for adolescence: Proposing NeuroD1 as a biomarker of its long-term plasticity.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2025-12-01 Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping ReviewQeios · 2025-11-21 Dissimilar Reactions and Enzymes for Psilocybin Biosynthesis in Inocybe and Psilocybe Mushrooms.Angewandte Chemie (International ed. in English) · 2025-11-10 Psychedelics in the Treatment of Neurologic and Psychiatric Disorders: Coincidence or a New Point of View.Molecular neurobiology · 2025-11-01 Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacity: A Scoping ReviewPreprints.org · 2025-10-17 Clinical psychedelic research in adolescents: a scoping review and overview of ethical considerations.The Lancet. Child & adolescent health · 2025-10-01 Regional Specificity of the Cingulate Cortex Thickness Association with the Intensity of Psilocybin Experience: A Replication StudyResearch Square · 2025-09-25 Psilocybin-assisted psychotherapy for methamphetamine use disorder: A pilot open-label safety and feasibility study.Addiction (Abingdon, England) · 2025-09-20 A critical evaluation of psilocybin-assisted therapy protocol components from clinical trial patients, facilitators, and caregivers.Psychotherapy (Chicago, Ill.) · 2025-09-01 Psychedelic Therapy, Positive Emotional Experiences, and the Central Role of Self-Compassion.Research square · 2025-08-22 Clinical Psychedelic Therapy Research Involving Adolescents: Protocol for a Scoping Review of Intervention StudiesWellcome Open Res · 2025-07-08 Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trial.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2025-07-01 ALSUntangled #77: Psilocybin.Amyotrophic lateral sclerosis & frontotemporal degeneration · 2025-05-01 The intensity of the psychedelic experience is reliably associated with clinical improvements: A systematic review and meta-analysis.Neuroscience and biobehavioral reviews · 2025-05-01 Exploring Factors Affecting Psychological Flexibility After Psychedelic Experiences.Journal of psychoactive drugs · 2025-04-25 458. Microdoses of Psilocybin Combined With Eugenol are Absorbed and Induce Unique Cerebellar Gene ExpressionBiological Psychiatry · 2025-04-09 Exploring factors associated with the intensity of a mystical experience following naturalistic psychedelic use: A retrospective survey.Progress in neuro-psychopharmacology & biological psychiatry · 2025-03-20 Prevalence and Correlates of Lifetime Ecstasy/MDMA Use Among Asian American and Pacific Islander Adult Populations in the United States, 2015-2020.Journal of psychoactive drugs · 2025-03-03 Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder.The Journal of clinical psychiatry · 2025-03-03 The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.Journal of affective disorders · 2025-03-01 Serotonergic Psychedelics Rapidly Modulate Evoked Glutamate Release in Cultured Cortical Neurons.Journal of neurochemistry · 2025-03-01 Prolonged adverse effects from repeated psilocybin use in an underground psychedelic therapy training program: a case report.BMC psychiatry · 2025-02-28 Emerging Medications for Treatment-Resistant Depression: A Review with Perspective on Mechanisms and Challenges.Brain sciences · 2025-02-06 Substrate recognition by the 4-hydroxytryptamine kinase PsiK in psilocybin biosynthesis.FEBS letters · 2025-02-01 Use of psychedelic treatments in psychiatric clinical practice: an EPA policy paper.European psychiatry: the journal of the Association of European Psychiatrists · 2025-01-10 A review of psychedelics trials completed in depression, informed by European regulatory perspectives.Neuroscience applied · 2025-01-01 : A new species from central Florida, with notes on and.Mycologia · 2025-01-01 Self-administered complementary and alternative methods of treating mental disorders among students in Wrocław: a cross-sectional study.Frontiers in public health · 2025-01-01 The Second Methylation in Psilocybin Biosynthesis Is Enabled by a Hydrogen Bonding Network Extending into the Secondary Sphere Surrounding the Methyltransferase Active Site.Chembiochem: a European journal of chemical biology · 2024-12-02 Human brain changes after first psilocybin usebioRxiv · 2024-10-14 Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder.Expert opinion on emerging drugs · 2024-09-01 SPONTANEOUS CHANGES IN CIGARETTE SMOKING FOLLOWING PSILOCYBIN-ASSISTED TREATMENT FOR ALCOHOL USE DISORDERDrug and Alcohol Dependence · 2024-07-01 Differing Approaches to Investigating the Therapeutic Efficacy of Psilocybin Across Diverse IndicationsDrug and Alcohol Dependence · 2024-07-01 Effect of chemically synthesized psilocybin and psychedelic mushroom extract on molecular and metabolic profiles in mouse brain.Molecular psychiatry · 2024-07-01 Ketamine-Induced Unresponsiveness Shows a Harmonic Shift from Global to Localised Functional OrganisationbioRxiv · 2024-06-25 Comparing Neural Correlates of Consciousness: From Psychedelics to Hypnosis and Meditation.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2024-05-01 Safety and risk assessment of psychedelic psychotherapy: A meta-analysis and systematic review.Psychiatry research · 2024-05-01 300 Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: An fMRI pilot studyJournal of clinical and translational science · 2024-04-24 Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial.Scientific reports · 2024-04-17 The psychedelic call: analysis of Australian Poisons Information Centre calls associated with classic psychedelics.Clinical toxicology (Philadelphia, Pa.) · 2024-04-01 Methyl transfer in psilocybin biosynthesis.Nature communications · 2024-03-28 Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT receptor the unique player?Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2024-03-01 Effects of psilocybin and sleep quality on brain water diffusivity and microstructure in healthy individuals and chronic cluster headache patientsNeuroscience Applied · 2024-01-01 CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity.Headache · 2024-01-01 The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.Current neuropharmacology · 2024-01-01 Valuing the Acute Subjective Experience.Perspectives in biology and medicine · 2024-01-01 Strong Bipartisan Support for Controlled Psilocybin Use as Treatment or Enhancement in a Representative Sample of US Americans: Need for Caution in Public Policy Persists.AJOB neuroscience · 2024-01-01 Potential use of psilocybin drugs in the treatment of depression.Expert opinion on emerging drugs · 2023-12-01 Beyond the 5-HT Receptor: Classic and Nonclassic Targets in Psychedelic Drug Action.The Journal of neuroscience: the official journal of the Society for Neuroscience · 2023-11-08 Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.JAMA · 2023-09-05 Substance use, harm reduction attitudes and behaviors among attendees of nature rave parties in Israel.Harm reduction journal · 2023-08-09 Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial.Journal of psychopharmacology (Oxford, England) · 2023-07-01 Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms.Journal of psychopharmacology (Oxford, England) · 2023-07-01 Psychedelics, Meaningfulness, and the "Proper Scope" of Medicine: Continuing the Conversation.Cambridge quarterly of healthcare ethics: CQ: the international journal of healthcare ethics committees · 2023-06-27 Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.Journal of affective disorders · 2023-04-14 Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey.Frontiers in psychiatry · 2023-01-01 Characterization of the Gateway Decarboxylase for Psilocybin Biosynthesis.Chembiochem: a European journal of chemical biology · 2022-12-16 Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.The New England journal of medicine · 2022-11-03 New investigational agents for the treatment of major depressive disorder.Expert opinion on investigational drugs · 2022-10-01 Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language ProcessingPsyArXiv · 2022-09-30 Interplay of hydrogen bonding in deciding the conformers of psilocin: Computational insightsAuthorea Preprints · 2022-09-01 The Use of Psychedelics in the Treatment of Medical Conditions: An Analysis of Currently Registered Psychedelics Studies in the American Drug Trial Registry.Cureus · 2022-09-01 Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness.Journal of palliative medicine · 2022-08-01 Analytical profile, in vitro metabolism and behavioral properties of the lysergamide 1P-AL-LAD.Drug testing and analysis · 2022-08-01 Psilocybin-induced reduction in chronic cluster headache attack frequency correlates with changes in hypothalamic functional connectivitymedRxiv · 2022-07-10 Psilocybin-Mediated Attenuation of Gamma Band Auditory Steady-State Responses (ASSR) Is Driven by the Intensity of Cognitive and Emotional Domains of Psychedelic Experience.Journal of personalized medicine · 2022-06-19 Attitudes and Beliefs about the Therapeutic Use of Psychedelic Drugs among Psychologists in the United States.Journal of psychoactive drugs · 2022-01-01 Psilocybin Induces Aberrant Prediction Error Processing of Tactile Mismatch Responses-A Simultaneous EEG-FMRI Study.Cerebral cortex (New York, N.Y.: 1991) · 2021-11-23 Spiritual experiences in psychedelic-assisted psychotherapy: Case reports of communion with the divine, the departed, and saints in research using psilocybin for the treatment of alcohol dependence.Spirituality in Clinical Practice · 2021-09-01 Psilocybin, Spirituality, and Palliative Care: Research and ImplicationsAlternative and Complementary Therapies · 2021-01-13 The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant ActionInstitutional Repositories DataBase (IRDB) · 2020-12-03 Psilocybin Induces Time-Dependent Changes in Global Functional Connectivity.Biological psychiatry · 2020-07-15 Enzymatic Route toward 6-Methylated Baeocystin and Psilocybin.Chembiochem: a European journal of chemical biology · 2019-11-18 Psilocybin for depression: Considerations for clinical trial designJournal of Psychedelic Studies · 2019-09-01 Mushroom Poisoning Cases in Dogs and Cats: Diagnosis and Treatment of Hepatotoxic, Neurotoxic, Gastroenterotoxic, Nephrotoxic, and Muscarinic Mushrooms.The Veterinary clinics of North America. Small animal practice · 2018-11-01 Facile assembly and fluorescence-based screening method for heterologous expression of biosynthetic pathways in fungi.Metabolic engineering · 2018-07-01 Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing-study on P300 and mismatch negativity in healthy volunteers.Psychopharmacology · 2018-02-01 Individual Experiences in Four Cancer Patients Following Psilocybin-Assisted Psychotherapy.Frontiers in pharmacology · 2018-01-01 Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related DistressJournal of Humanistic Psychology · 2017-06-14 Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological AnalysisJournal of Humanistic Psychology · 2017-04-28 No clinically relevant effects in children after accidental ingestion of Panaeolina foenisecii (lawn mower's mushroom).Clinical toxicology (Philadelphia, Pa.) · 2017-03-01 Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences.Journal of psychopharmacology (Oxford, England) · 2016-12-01 Development of a Psychotherapeutic Model for Psilocybin-Assisted Treatment of AlcoholismJournal of Humanistic Psychology · 2016-10-16 Survey study of challenging experiences after ingesting psilocybin mushrooms: Demographics and phenomenologyDrug and Alcohol Dependence · 2014-12-16 The challenging experience questionnaire: Characterization of acute adverse reactions to psilocybinDrug and Alcohol Dependence · 2014-12-16 Characterization of challenging experiences (i.e., bad trips) after ingesting psilocybinDrug and Alcohol Dependence · 2014-06-07 Bioanalytical and clinical evaluation of 103 suspected cases of intoxications with psychoactive plant materials.Clinical toxicology (Philadelphia, Pa.) · 2009-07-01 [Chronic cluster headache: Response to psilocybin].Revista de neurologia · 2006-01-01 The effects of psychoactive drugs and neuroleptics on language in normal subjects and schizophrenic patients: a review.European psychiatry: the journal of the Association of European Psychiatrists · 2000-12-01 Investigations On Psilocybin And Its Analogs In Certain Fungi.Deep Blue (University of Michigan) · 1966-12-31

Author directory